Physician
Dayrit, Melvin
Dayrit, Melvin was paid $519.62 by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 76% of everything it billed.
33Billing provider infoDAYRIT, MELVIN
LOS ANGELES, CA 90003
LOS ANGELES, CA 90003
33aNPI1518063676assigned 09/16/2006
33bProvider typeFamily Medicine Physician
28Total paid$519.62
24GClaims55,020
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#1,949 of 2,511
Median peer was paid$13K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,409 | $340.32 | |
| 2019 | 1,756 | $179.30 | |
| 2020 | 7,861 | $0.00 | |
| 2021 | 10,150 | $0.00 | |
| 2022 | 8,335 | $0.00 | |
| 2023 | 8,786 | $0.00 | |
| 2024incomplete | 15,723 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 76% | 3,983 | 3,167 | $397.04 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 16% | 4,267 | 3,700 | $85.08 |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.2% | 965 | 901 | $37.50 |
| 82540 | 0% | 1,374 | 1,360 | $0.00 | |
| 80061 | Lipid panel | 0% | 3,428 | 3,407 | $0.00 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 150 | 93 | $0.00 |
| 99442 | 0% | 1,047 | 1,009 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 753 | 743 | $0.00 |
| 86703 | 0% | 1,435 | 1,424 | $0.00 | |
| 82947 | 0% | 385 | 383 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 153 | 150 | $0.00 |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 0% | 155 | 144 | $0.00 |
57 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 736 | $0.00 |
| 82274 | 0% | 920 | $0.00 | |
| 91300 | 0% | 65 | $0.00 | |
| 3078F | 0% | 1,194 | $0.00 | |
| 85610 | 0% | 201 | $0.00 | |
| 3051F | 0% | 68 | $0.00 | |
| 90653 | 0% | 14 | $0.00 | |
| 3077F | 0% | 437 | $0.00 | |
| 84439 | 0% | 136 | $0.00 | |
| 84450 | 0% | 167 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 12 | $0.00 |
| 90658 | 0% | 12 | $0.00 | |
| 84460 | 0% | 53 | $0.00 | |
| 3046F | 0% | 15 | $0.00 | |
| 81003 | 0% | 25 | $0.00 | |
| 4450F | 0% | 457 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 1,720 | $0.00 |
| 87522 | Neg quan hep c or qual rna | 0% | 327 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 241 | $0.00 |
| 99441 | 0% | 102 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 2,973 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 1,468 | $0.00 |
| 85027 | 0% | 1,717 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 1,852 | $0.00 |
| 99443 | 0% | 279 | $0.00 | |
| 86593 | 0% | 536 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 4,219 | $0.00 |
| 3074F | 0% | 867 | $0.00 | |
| 86780 | 0% | 194 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 753 | $0.00 |
| 3079F | 0% | 328 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 7,639 | $0.00 |
| 3052F | 0% | 14 | $0.00 | |
| 1111F | 0% | 346 | $0.00 | |
| 82043 | 0% | 1,374 | $0.00 | |
| 81001 | 0% | 556 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 1,488 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 638 | $0.00 |
| 1220F | 0% | 846 | $0.00 | |
| 91301 | 0% | 17 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 120 | $0.00 |
| 3044F | 0% | 486 | $0.00 | |
| 3075F | 0% | 330 | $0.00 | |
| 82607 | 0% | 134 | $0.00 | |
| 94760 | 0% | 93 | $0.00 | |
| 3080F | 0% | 164 | $0.00 | |
| 92250 | 0% | 46 | $0.00 | |
| 90656 | 0% | 44 | $0.00 | |
| D1330 | 0% | 49 | $0.00 | |
| 86592 | 0% | 183 | $0.00 | |
| 84153 | 0% | 13 | $0.00 | |
| 85652 | 0% | 12 | $0.00 | |
| D0140 | Limited oral evaluation - problem focused | 0% | 90 | $0.00 |
| 87340 | 0% | 27 | $0.00 | |
| 87088 | 0% | 24 | $0.00 | |
| 91306 | 0% | 12 | $0.00 | |
| 90686 | 0% | 92 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.